| Pharmaceutical Information |
| Drug Name |
Bethanechol |
| Drug ID |
BADD_D00265 |
| Description |
Bethanechol is a synthetic ester that was initially synthesized in 1935.[A232905,L32539] As a cholinergic agent, bethanechol is similar in structure and pharmacological function to acetylcholine and is used in specific cases when stimulation of the parasympathetic nervous system is necessary.[A232905,L32539] For example, bethanechol is readily used to treat postoperative or postpartum urinary retention. An advantage of bethanechol is that in contrast to acetylcholine, bethanechol is not degraded by cholinesterase allowing its effects to be longer-lasting.[L32539] |
| Indications and Usage |
Bethanechol is indicated for the treatment of acute, functional postpartum and postoperative urinary retention. It is also indicated for the treatment of neurogenic atony of the bladder with retention.[A226320,L32539] |
| Marketing Status |
approved |
| ATC Code |
N07AB02 |
| DrugBank ID |
DB01019
|
| KEGG ID |
D01000
|
| MeSH ID |
D018723
|
| PubChem ID |
2370
|
| TTD Drug ID |
D07ZTO
|
| NDC Product Code |
Not Available |
| UNII |
004F72P8F4
|
| Synonyms |
Bethanechol | Bethanecol | Bethanechol Chloride | Chloride, Bethanechol | Duvoid | Myotonine | Myocholine | PMS-Bethanechol Chloride | PMS Bethanechol Chloride | Urocarb | Myotonachol | Urecholine | Myo Hermes | Hermes, Myo |
|
| Chemical Information |
| Molecular Formula |
C7H17N2O2+ |
| CAS Registry Number |
674-38-4 |
| SMILES |
CC(C[N+](C)(C)C)OC(=O)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
